Medtech InsightHearing implant firm Cochlear Ltd. announced on 22 April it received expanded US Food and Drug Administration clearance for use of its Osia System, allowing “people across all stages of life to stay
In VivoA lack of approved pharmacological therapies for hearing loss, whether acquired or congenital, is a gap in the market that a number of biotechs and big pharmaceutical firms are looking to plug. While
ScripCOVID-related revisions to a high-profile Veltassa Phase IIIb trial, and the appointment of a new CEO, ex-GSK executive Abbas Hussain, have punctuated the week at Switzerland’s specialty company, Vif
Medtech InsightThe latest Medtech Insight sales ranking of the top 100 publicly-traded medtech manufacturers is COVID-19-affected for a relatively sizeable proportion of companies ̶ those whose reporting perio